Pyrolysis of UR-144, a synthetic cannabinoid, augments an affinity to human CB1 receptor and cannabimimetic effects in mice

被引:18
作者
Kaizaki-Mitsumoto, Asuka [1 ]
Hataoka, Kyoko [1 ]
Funada, Masahiko [2 ]
Odanaka, Yuki [3 ]
Kumamoto, Hiroki [4 ]
Numazawa, Satoshi [1 ]
机构
[1] Showa Univ, Sch Pharm, Div Toxicol,Dept Pharmacol Toxicol & Therapeut, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan
[3] Showa Univ, Sch Pharm, Ctr Instrumental Anal, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan
[4] Showa Univ, Sch Pharm, Dept Med & Ind Chem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan
关键词
UR-144; Synthetic cannabinoid; Smoking; degradant; CB1; receptor;
D O I
10.2131/jts.42.335
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Drug abusers most often smoke 'herbal incense' as a cigarette or inhale it using a smoking tool. Smoking may cause pyrolysis of the drug and produce decomposed products of which biological effect has never been investigated. The synthetic cannabinoid UR-144 is known to undergo thermal degradation, giving a ring-opened isomer, so-called UR-144 degradant. The present study demonstrates by using UR-144 as a model drug that the smoke of burned UR-144 contains the UR-144 degradant. The UR-144 degradant showed approximately four fold higher agonist activity to human CB, receptor and augmented hypothermic and akinetic actions in mice compared to UR-144. These results indicate that smoking behavior may increase psychological actions of the certain synthetic cannabinoids.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 10 条
[1]   Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 [J].
Banister, Samuel D. ;
Stuart, Jordyn ;
Kevin, Richard C. ;
Edington, Amelia ;
Longworth, Mitchell ;
Wilkinson, Shane M. ;
Beinat, Corinne ;
Buchanan, Alexandra S. ;
Hibbs, David E. ;
Glass, Michelle ;
Connor, Mark ;
McGregor, Iain S. ;
Kassiou, Michael .
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (08) :1445-1458
[2]   Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity [J].
Frost, Jennifer M. ;
Dart, Michael J. ;
Tietje, Karin R. ;
Garrison, Tiffany R. ;
Grayson, George K. ;
Daza, Anthony V. ;
El-Kouhen, Odile F. ;
Yao, Betty B. ;
Hsieh, Gin C. ;
Pai, Madhavi ;
Zhu, Chang Z. ;
Chandran, Prasant ;
Meyer, Michael D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :295-315
[3]   Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market [J].
Gatch, Michael B. ;
Forster, Michael J. .
BEHAVIOURAL PHARMACOLOGY, 2015, 26 (05) :460-468
[4]   UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products [J].
Kavanagh, Pierce ;
Grigoryev, Andrej ;
Savchuk, Sergey ;
Mikhura, Irina ;
Formanovsky, Andrew .
DRUG TESTING AND ANALYSIS, 2013, 5 (08) :683-692
[5]   Characterizing the intersection of Co-occurring risk factors for illicit drug abuse and dependence in a US nationally representative sample [J].
Kurti, Allison N. ;
Keith, Diana R. ;
Noble, Alyssa ;
Priest, Jeff S. ;
Sprague, Brian ;
Higgins, Stephen T. .
PREVENTIVE MEDICINE, 2016, 92 :118-125
[6]   MAM-2201 (Analytically Confirmed) Intoxication After "Synthacaine" Consumption [J].
Lonati, Davide ;
Buscaglia, Eleonora ;
Papa, Pietro ;
Valli, Antonella ;
Coccini, Teresa ;
Giampreti, Andrea ;
Petrolini, Valeria Margherita ;
Vecchio, Sarah ;
Serpelloni, Giovanni ;
Locatelli, Carlo Alessandro .
ANNALS OF EMERGENCY MEDICINE, 2014, 64 (06) :629-632
[7]   A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure [J].
Louh, Irene K. ;
Freeman, William D. .
CRITICAL CARE, 2014, 18 (05)
[8]  
Numazawa S, 2013, SHOWA U J PHARM SCI, V4, P13
[9]   Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles [J].
Wiley, Jenny L. ;
Marusich, Julie A. ;
Lefever, Timothy W. ;
Grabenauer, Megan ;
Moore, Katherine N. ;
Thomas, Brian F. .
NEUROPHARMACOLOGY, 2013, 75 :145-154
[10]   Cannabinoid pharmacological properties common to other centrally acting drugs [J].
Wiley, JL ;
Martin, BR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (03) :185-193